Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.

Rebecca WellmannBrittany A BordenKeith DanaheyRita NandaBlasé N Polite Walter M StadlerMark J RatainPeter H O'Donnell

Published in: Cancer (2018)

Several oncology drugs have actionable germline pharmacogenomic information, justifying their delivery through institutional pharmacogenomic implementations to determine clinical utility. Cancer 2018;124:3052-65. © 2018 American Cancer Society.

Keyphrases

papillary thyroid
palliative care
squamous cell
clinical decision support
dna repair
squamous cell carcinoma
healthcare